Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
JAMA Oncology|August 30, 2019
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical TrialCarlos Fernández-Martos, Carles Pericay, Ferran Losa, et al.Cancer Medicine|December 19, 2019
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)Jaime Feliu, Rocio Garcia-Carbonero, Jaume Capdevila, et al.Cancers|July 12, 2025
Treatment and Outcomes in Advanced Gastroesophageal Adenocarcinoma in the Pre-Immunotherapy Era Based on the Spanish AGAMENON-SEOM RegistryPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Jaime Álvarez-Cañada, et al.Journal of Cancer Research and Clinical Oncology|August 30, 2022
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registrySena Valcarcel, Javier Gallego, Paula Jimenez-Fonseca, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 16, 2024
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registryAranzazu Arias-Martinez, Eva Martínez de Castro, Javier Gallego, et al.Pageof 2